Influence of chemical structure on skin reactions induced by antiepileptic drugs-The role of the aromatic ring

Epilepsy Research

Volumn 94, Issue 3, 2011, Pages 213-217

  Wang, Xiang qing ^a   Shi, Xiao bing ^a   Au, Ran ^a   Chen, Fu shun ^a   Wang, Fang ^a   Lang, Sen yang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Antiepileptic drugs; Aromatic ring; Chinese population; Gender; Skin reactions

Indexed keywords

ANTICONVULSIVE AGENT; AROMATIC COMPOUND; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DRUG STRUCTURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SEX DIFFERENCE; SKIN MANIFESTATION; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; ANTICONVULSANTS; DRUG HYPERSENSITIVITY; EPILEPSY; EXANTHEMA; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; STRUCTURE-ACTIVITY RELATIONSHIP; YOUNG ADULT;

EID: 79955522997     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.02.005     Document Type: Article

References (19)

1. Arif H., Buchsbaum R., Weintraub D., Koyfman S., Salas-Humara C., Bazil C.W., Resor SR., Hirsch L.J. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 2007, 68:1701-1709. (PubMed: 17502552).
2. Arroyo S., de la Morena A. Life-threatening adverse events of antiepileptic drugs. Epilepsy Res. 2001, 47:155-174. (PubMed: 11673030).
3. Brown C.E., Smith G.D., Coniglione T. Anticonvulsant hypersensitivity: an unfortunate case of triple exposure to phenytoin. J. Fam. Pract. 1997, 45:434-437. (PubMed: 9374970).
4. Chadwick D. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multi centre randomized double blind study. Vigabatrin European Monotherapy Study Group. Lancet 1999, 354:13-19. (PubMed: 10406359).
5. Chung W.H., Hung S.I., Hong H.S., Hsih M.S., Yang L.C., Ho H.C., Wu J.Y., Chen Y.T. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004, 428:486. (PubMed: 15057820).
6. Cumbo-Nacheli G., Weinberger J., Alkhalil M., Thati N., Baptist A.P. Anticonvulsant hypersensitivity syndrome: is there a role for immunomodulation?. Epilepsia 2008, 49:2108-2112. (PubMed: 18637830).
7. Gomes E.R., Demoly P. Epidemiology of hypersensitivity drug reactions. Curr. Opin. Allergy Clin. Immunol. 2005, 5:309-316. (PubMed: 15985812).
8. Handoko K.B., van Puijenbroek E.P., Bijl A.H., Hermens W.A., Zwart-van Rijkom J.E., Hekster Y.A., Egberts T.C. Influence of chemical structure on hypersensitivity reactions induced by antiepileptic drugs: the role of the aromatic ring. Drug Saf. 2008, 31:695-702. (PubMed: 18636788).
9. Hyson C., Sadler M. Cross sensitivity of skin rashes with antiepileptic drugs. Can. J. Neurol. Sci. 1997, 24:245-249. (PubMed: 9276112).
10. Jerina D.M., Daly J.W. Arene oxide: a new aspect of drug metabolism. Science 1974, 185:573-582. (PubMed: 4841570).
11. Klassen B.D., Sadler R.M. Induction of hypersensitivity to a previously tolerated antiepileptic drug by a second antiepileptic drug. Epilepsia 2001, 42:433-435. (PubMed: 11442165).
12. Knowles S.R., Shapiro L.E., Shear N.H. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf. 1999, 21:489-501. (PubMed: 10612272).
13. Mockenhaupt M., Messenheimer J., Tennis P., Schlingmann J. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 2005, 64:1134-1138. (PubMed: 15824335).
14. Naisbitt D.J., Farrell J., Wong G., Depta J.P., Dodd C.C., Hopkins J.E., Gibney C.A., Chadwick D.W., Pichler W.J., Pirmohamed M., Park B.K. Characterization of drug-specific T cells in lamotrigine hypersensitivity. J. Allergy Clin. Immunol. 2003, 111:1393-1403. (PubMed: 12789244).
15. Newell B.D., Moinfar M., Mancini A.J., Nopper A.J. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS). Pediatr. Dermatol. 2009, 26:536-546. (PubMed: 19840307).
16. Park B.K., Pirmohamed M., Kitteringham N.R. Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem. Res. Toxicol. 1998, 11:969-988. (PubMed: 9760271).
17. Pichler W.J. Delayed drug hypersensitivity reactions. Ann. Intern. Med. 2003, 139:683-693. (PubMed: 14568857).
18. Riedl M.A., Casillas A.M. Adverse drug reactions: types and treatment options. Am. Fam. Physician 2003, 68:1781-1790. (PubMed: 14620598).
19. Shear N.H., Spielberg S.P. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J. Clin. Invest. 1988, 82:1826-1832. (PubMed: 3198757).